ScholarIQanswers from OpenAlex & ORCID
Sven Francque
ResearcherPublications, citations & collaboration network
Sven Francque is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Sven Francque have?
ScholarIQindexed works
Sven Francque has 446 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Sven Francque have?
ScholarIQcitation count
Sven Francque has 37,149 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Sven Francque?
ScholarIQh-index
Sven Francque has an h-index of 80 in OpenAlex.
What is the i10-index of Sven Francque?
ScholarIQi10-index
Sven Francque has an i10-index of 199 in OpenAlex.
What is the ORCID of Sven Francque?
ScholarIQorcid
The ORCID for Sven Francque is on the source record.
What is the OpenAlex record for Sven Francque?
ScholarIQopenalex
The OpenAlex for Sven Francque is on the source record.
What are the most-cited papers on Sven Francque?
ScholarIQmost cited works
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramón Bataller, Ulrich Beuers, Jérôme Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela Castro‐Narro, Abhijit Chowdhury, Helena Cortez‐Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El‐Kassas, Samuel Klein, Wayne Eskridge, Jian‐Gao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G.P. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome, on behalf of the NAFLD Nomenclature consensus group
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramón Bataller, Ulrich Beuers, Jérôme Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela Castro‐Narro, Abhijit Chowdhury, Helena Cortez‐Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El‐Kassas, Samuel Klein, Wayne Eskridge, Jian‐Gao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G.P. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome
Baveno VII – Renewing consensus in portal hypertension
Roberto de Franchis, Jaime Bosch, Guadalupe García–Tsao, Thomas Reiberger, Cristina Ripoll, Juan G. Abraldeṣ, Agustı́n Albillos, Anna Baiges, Jasmohan S. Bajaj, Rafael Bañares, Marta Barrufet, Lina Benajiba, Annalisa Berzigotti, Christophe Bureau, Vincenza Calvaruso, Andrés Cárdenas, Gennaro D’Amico, Andrea De Gottardi, Alessandra Dell’Era, Àngels Escorsell, Jonathan Fallowfield, Héctor Ferral, Sven Francque, Ron C. Gaba, Juan Carlos García‐Pagán, Joan Genescà, Susana Rodrigues, Jordi Gracia‐Sancho, Guogong Han, Virginia Hernández–Gea, Jidong Jia, Jean‐Jacques Kiladjian, Aleksander Krag, Wim Laleman, Vincenzo La Mura, Sabela Lens, Xuefeng Luo, Mattias Mandorfer, Sarwa Darwish Murad, Valérie Paradis, David Patch, Salvatore Piano, Massimo Pinzani, Aurélie Plessier, Massimo Primignani, Bogdan Procopeț, Pierre‐Emmanuel Rautou, Marika Rudler, Shiv Kumar Sarin, Filippo Schepis, Marco Senzolo, Vijay H. Shah, Akash Shukla, Puneeta Tandon, Luís Téllez, Dominique Thabut, Maja Thiele, Jonel Trebicka, Dhiraj Tripathi, Emmanouil Tsochatzis, Laura Turco, Fanny Turón, Dominique Valla, Càndid Villanueva, Ian R. Wanless, Hitoshi Yoshiji
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Stephen A. Harrison, Pierre Bédossa, Cynthia D. Guy, Jörn M. Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E. Moussa, Guy Neff, Mary E. Rinella, Quentin M. Anstee, Manal F. Abdelmalek, Zobair M. Younossi, Seth J. Baum, Sven Francque, Michael Charlton, Philip N. Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M. Pericàs, Rashmee Patil, Arun J. Sanyal, Mazen Noureddin, Meena B. Bansal, Naim Alkhouri, Laurent Castéra, Madhavi Rudraraju, Vlad Ratziu
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, Vlad Ratziu, Elisabetta Bugianesi, Sven Francque, Shira Zelber‐Sagi, Luca Valenti, Michael Roden, Fritz Schick, Hannele Yki‐Järvinen, Amalia Gastaldelli, Roberto Vettor, Gema Frühbeck, Dror Dicker